Fennec Pharmaceuticals Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for FENC, updated each market day.
FENC AI Sentiment
AI sees no strong directional signal for Fennec Pharmaceuticals Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Fennec Pharmaceuticals Inc. Common Stock
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Sector
Exchange
Market Cap
$220,641,139
Cap Tier
Employees
35
Headquarters
RESEARCH TRIANGLE PARK, NC
Listed Since
Jan. 28, 2002
Website
FENC Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
FENC Volatility
Fennec Pharmaceuticals Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
